|
Market Closed -
Boerse Muenchen
00:43:26 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 83.55 EUR | +0.66% |
|
-6.16% | +2.09% |
| 09-12 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 68.24B | |||||
| 62.23B | |||||
| 27.8B | - | ||||
| 24.86B | |||||
| 24.22B | - |
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Charts BioNTech SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
